Dr Jason Loveridge appointed new CEO of 4SC
4SC AG / Key word(s): Change of Personnel
21.09.2016 14:31
Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
—————————————————————————
Dr Jason Loveridge appointed new CEO of 4SC
Planegg-Martinsried, Germany, 21 September 2016 – The Supervisory Board of
4SC AG (4SC, FSE Prime Standard: VSC) today appointed Dr Jason Loveridge as
new CEO of 4SC. He accepted the appointment and will assume the position
effective today.
Jason Loveridge graduated in Biochemistry and Microbiology from the
University of New South Wales, Australia, and holds a Ph.D. in Biochemistry
from the University of Adelaide, Australia. He has more than 20 years of
international experience across Europe, Asia and the US in senior
management positions in life sciences companies and as an investment
professional dealing in both privately held and publicly traded companies.
Jason Loveridge also brings substantial transactional experience in the
sale and partnering of biotechnology assets to 4SC, which the Supervisory
Board believes complements the current team and will help to maximize value
for shareholders.
—————————————————————————
Information and Explanation of the Issuer to this News:
About 4SC
4SC (www.4sc.com) is a biotech company dedicated to the research and
development of small-molecule drugs focused on epigenetic mechanisms of
action for the treatment of cancers with high unmet medical needs. These
drugs are intended to provide innovative treatment options for cancer
patients that are more tolerable and efficacious than existing therapies,
provide a better quality of life and offer increased life expectancy. The
Company’s pipeline comprises promising products that are in various stages
of clinical development. 4SC’s aim is to generate future growth and enhance
its enterprise value by entering into partnerships with pharmaceutical and
biotech companies. Founded in 1997, 4SC had 50 employees as of 30 June
2016. 4SC has been listed on the Prime Standard of the Frankfurt Stock
Exchange since December 2005.
Forward-looking information
Information set forth in this press release contains forward-looking
statements, which involve a number of risks and uncertainties. The forward-
looking statements contained herein represent the judgement of 4SC as of
the date of this presentation. Such forward-looking statements are neither
promises nor guarantees, but are subject to a variety of risks and
uncertainties, many of which are beyond 4SC’s control, and which could
cause actual results to differ materially from those contemplated in these
forward-looking statements. 4SC expressly disclaims any obligation or
undertaking to release any updates or revisions to any such statements to
reflect any change in its expectations or any change in events, conditions
or circumstances on which any such statement is based.
Contact
4SC Corporate Communications & Investor Relations
Wolfgang Güssgen, email hidden; JavaScript is required, +49 89 700763-73
Dr Anna Niedl, email hidden; JavaScript is required, +49 89 700763-66
MC Services
Katja Arnold, email hidden; JavaScript is required, +49 89 210228-40
The Ruth Group
Carol Ruth, email hidden; JavaScript is required, +1 646 536 7004
21.09.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
—————————————————————————